How age-related testosterone change differs from clinical hypogonadism, why symptoms matter, and why a low test result needs context.
A morning blood sample is taken to measure testosterone.
The discussion turns to changes in desire or erections.
If the result is low, another measurement may be needed.
That is a more useful starting point than assuming that every midlife sexual change has a hormonal explanation. Age provides context. A person's symptoms and the conditions of testing provide context too.
Mayo Clinic describes testosterone as declining by about 1% per year after age 30 or 40. This is a typical age-related pattern, not a timetable every man follows or a diagnosis in itself.
The distinction matters because ordinary aging and clinically low testosterone are not interchangeable ideas. Mayo Clinic advises considering whether a low result reflects normal aging or hypogonadism. A birthday alone does not answer that question.
There is no need to treat getting older as evidence that sexual wellbeing is failing. The useful question is whether a particular change deserves assessment in the context of that person's health and experience.
For a wider view, Sexential's discussion of hormonal changes across adulthood places testosterone within the broader subject of sexual health as we age.
The European Association of Urology (EAU) lists reduced libido, erectile dysfunction and fewer spontaneous or morning erections among the more specific symptoms associated with late-onset hypogonadism. Its guidance distinguishes these sexual symptoms from less specific physical and psychological symptoms.
That makes the description of a change important. Lower interest in sex is not the same observation as difficulty with erections. Feeling tired or low in mood is another kind of concern and should be described in its own terms.
Rather than putting everything under the label of low testosterone, it is more useful to identify what has actually changed. Is desire lower than it used to be? Are erections different? Is tiredness the main concern rather than sexual function?
Lifestyle and relationship context also deserve space in that account. Consider whether routines or expectations have changed and what concerns you most about the experience. These are questions for a fuller conversation, not a checklist for assigning a hormonal cause.
The psychological side belongs in the discussion too. Worry about a change can be mentioned alongside the change itself. There is no need to present only physical observations or to decide in advance which part of the experience matters most.
A useful starting point is the person's own experience rather than a comparison with other men. People differ in desire, sexual function and relationship preferences. They also differ in how much importance they place on sex at a given stage of life.
A lower level of interest that feels acceptable to one person may be troubling to another. Someone else may be more concerned about erections than desire. Those distinctions help define the concern being discussed; they are not evidence of different levels of personal worth or masculinity.
Identity and relationship status should not be inferred from a hormone result. Neither should a person's priorities. The purpose of assessment is to understand a concern, not to fit everyone to one model of sexual activity.
This also leaves room for different goals. A person may want an explanation for a change or support in discussing it with a partner. Another may simply want to know whether a medical assessment is relevant.
EAU guidance bases a diagnosis of male hypogonadism on compatible signs or symptoms together with consistently low testosterone. Symptoms and laboratory findings are considered together. Neither is a substitute for the other.
The two parts of that standard answer different questions. The symptom history describes the concern that needs explaining. Repeated measurements help establish whether a low laboratory finding persists under the recommended conditions. Linking the two is the clinician's task, not something that a test report can do by itself.
The EAU recommends measuring total testosterone in the morning while fasting and using a reliable laboratory test. It calls for repeat testing on at least two separate occasions when testosterone is below 12 nmol/L, before treatment begins.
The reason for standardizing collection is practical. Testosterone varies during the day and between days, and food intake may affect the result. One measurement is therefore not necessarily a reliable account of a person's usual level.
The threshold in this guidance is part of a clinical assessment process. It is not a stand-alone instruction to start treatment. Questions about a result belong with the healthcare professional who can interpret the symptoms and testing conditions together.
Sexential's guide to putting a testosterone test in context offers further educational background for that conversation.
In a 2026 statement, the Endocrine Society said evidence is insufficient to support population-level screening of asymptomatic men. It also warned that screening men over 30 could produce many false-positive results.
A test is not automatically more informative because it is offered earlier in adulthood. The Society's warning is about the risk of identifying a problem that is not actually present. For someone without symptoms, that makes the reason for testing especially important to discuss.
Assessing a reported concern and screening someone without symptoms are different decisions. A useful question is what clinical problem a test is intended to clarify, rather than whether a number might explain aging in general.
The evidence discussed here concerns male hypogonadism and testing in men. It does not establish equivalent diagnostic criteria for women or show that testosterone explains any particular person's tiredness or sexual changes. That boundary is a reason to keep the assessment focused on the individual concern rather than promise a general improvement in energy.
When a change involves a relationship, the conversation does not need to begin with a theory about hormones. It can begin with the observation and what each person wants to understand.
A low result should not be treated as a verdict on attraction or commitment. Equally, a partner does not have to interpret a medical result or decide whether treatment is appropriate. Those are separate subjects.
It may help to distinguish personal experience from relationship expectations. One person may want to discuss lower desire while the other wants to discuss how often they spend time together. Naming those topics separately gives the conversation a clearer subject.
Mismatched desire can be discussed as a difference in current preferences rather than evidence that one partner is medically unwell. Questions about time together and preferred forms of closeness can sit alongside questions for a clinician. The relationship discussion and medical assessment do not have to answer the same question.
Sexential's guidance on discussing sexual changes with a partner supports that kind of calm exchange. The aim is understanding, not proving that one explanation must account for everything.
The next step is not to arrive with a diagnosis. It is to make the concern specific enough for a healthcare professional to assess.
There is no need to build a detailed hormone theory before seeking input. The practical questions are what you have noticed, how it relates to your usual experience and what you want help understanding. A healthcare professional can then consider which parts of the history and any laboratory findings belong together.
A written account of what you have noticed can organize the discussion without turning observation into self-diagnosis. Sexential's overview of what a sexual-health assessment involves provides context for preparing that conversation.
A change deserves a fair hearing, not an automatic label.
Deciding how to discuss a low testosterone result requires context beyond the number, and Sexential's educational role is to make that context clearer. For readers puzzled by shifts in libido or arousal, its explanations connect hormonal questions with real-life circumstances so that changes are easier to discuss without assuming a medical cause.
Follow Sexential for thoughtful guidance on desire, sexual function, hormones, confidence, relationships and intimacy. Explore new articles and evidence-aware resources for sexual wellbeing across adulthood.
A report on a student survey links attention with men’s sexual satisfaction. Here’s the evidence, its limits and the practical context for midlife.
A new report puts men’s midlife testosterone changes in context, with guidance on assessment, partner conversations and fertility considerations.
The Menopause Society’s 2026 program places lifestyle, sleep and sexual health together. Here is what the agenda and partner research actually report.
Explore practical resources on desire, function, hormones, confidence, intimacy and sexual wellbeing.
Read the Blog
